Sabine Mueller, Md, Phd
Clinical trials sponsored by Sabine Mueller, Md, Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill shows promise against childhood brain tumor Results expected Mar 2027 (estimated)
- New hope for kids with deadly brain cancer? drug ONC206 enters human trials Results expected May 2027 (estimated)
-
Immunotherapy drug nivolumab tested in young brain cancer patients
Disease control OngoingThis early-phase trial is testing the immunotherapy drug nivolumab in children and young adults whose high-grade glioma has come back or is getting worse. Participants receive the drug before and after surgery to remove as much of the tumor as possible. The main goals are to chec…
Phase 1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immune cells injected into brain tumors: a new hope for kids?
Disease control PausedThis early-phase trial tests whether natural killer (NK) cells from healthy donors can be safely injected into the brain tumors of children and young adults whose cancer has returned or is growing. The NK cells are specially treated to resist the tumor's defenses. The main goals …
Phase 1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC